Senior insider sale
President and Chairman at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$1.80M
300K shares
What this filing means
GAD THOMAS plans to sell 300K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $1.80M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/13/2023ACC: 0001968582-23-000768
DirectorOfficer· President and Chairman
Since Sep 2018
300K
Shares to sell
$1.80M
Approx. market value
150K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Private Investment
Cash
8/15/2015
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2015 | Private Investment Cash | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
75K
Market value
$393.0K
11/21/2023
—Completed
Units to sell
75K
Market value
$392.4K
11/20/2023
Planned — Approximate Date
NasdaqPlanned
Units to sell
150K
Market value
$1.02M
12/13/2023
Total
Units
300K
Value
$1.80M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/21/2023 | 75K | $393.0K | — | Completed |
11/20/2023 | 75K | $392.4K | — | Completed |
| Planned — Approximate Date | ||||
12/13/2023 | 150K | $1.02M | Nasdaq | Planned |
| Total | 300K | $1.80M | ||